Home
>
National Drug Code (NDC)
>
Dexamethasone Sodium Phosphate
Dexamethasone Sodium Phosphate - 63323-165-30 - (DEXAMETHASONE SODIUM PHOSPHATE)
Drug Information of Dexamethasone Sodium Phosphate
| Product NDC: | 63323-165 |
| Proprietary Name: | Dexamethasone Sodium Phosphate |
| Non Proprietary Name: | DEXAMETHASONE SODIUM PHOSPHATE |
| Active Ingredient(s): | 4 mg/mL & nbsp; DEXAMETHASONE SODIUM PHOSPHATE |
| Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Dexamethasone Sodium Phosphate
| Product NDC: | 63323-165 |
| Labeler Name: | APP Pharmaceuticals, LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA084916 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20000907 |
Package Information of Dexamethasone Sodium Phosphate
| Package NDC: | 63323-165-30 |
| Package Description: | 1 VIAL, MULTI-DOSE in 1 BOX (63323-165-30) > 30 mL in 1 VIAL, MULTI-DOSE |
NDC Information of Dexamethasone Sodium Phosphate
| NDC Code | 63323-165-30 |
| Proprietary Name | Dexamethasone Sodium Phosphate |
| Package Description | 1 VIAL, MULTI-DOSE in 1 BOX (63323-165-30) > 30 mL in 1 VIAL, MULTI-DOSE |
| Product NDC | 63323-165 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | DEXAMETHASONE SODIUM PHOSPHATE |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAMUSCULAR; INTRAVENOUS |
| Start Marketing Date | 20000907 |
| Marketing Category Name | ANDA |
| Labeler Name | APP Pharmaceuticals, LLC |
| Substance Name | DEXAMETHASONE SODIUM PHOSPHATE |
| Strength Number | 4 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |
